Healthcare -
Biotechnology - NASDAQ - US
$ 3.12
-8.5 %
$ 529 M
Market Cap
-1.32
P/E
RLAY - STOCK-BASED COMPENSATION
Stock-based Compensation RLAY - Relay Therapeutics, Inc.
86 M
LAST VALUE
33.25%
2 YEAR CAGR
97.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR